Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Current Assets (2020 - 2025)

Historic Current Assets for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $53603.7 billion.

  • Universe Pharmaceuticals' Current Assets rose 380.71% to $53603.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $53603.7 billion, marking a year-over-year increase of 380.71%. This contributed to the annual value of $53603.7 billion for FY2025, which is 380.71% up from last year.
  • Latest data reveals that Universe Pharmaceuticals reported Current Assets of $53603.7 billion as of Q3 2025, which was up 380.71% from $51637.8 billion recorded in Q3 2024.
  • Universe Pharmaceuticals' 5-year Current Assets high stood at $53603.7 billion for Q3 2025, and its period low was $25.3 million during Q3 2023.
  • In the last 5 years, Universe Pharmaceuticals' Current Assets had a median value of $51.1 million in 2021 and averaged $13155.2 billion.
  • In the last 5 years, Universe Pharmaceuticals' Current Assets crashed by 9999.98% in 2021 and then soared by 20434649588.05% in 2024.
  • Over the past 5 years, Universe Pharmaceuticals' Current Assets (Quarter) stood at $50.5 million in 2021, then fell by 17.78% to $41.5 million in 2022, then plummeted by 39.12% to $25.3 million in 2023, then surged by 204346495.88% to $51637.8 billion in 2024, then rose by 3.81% to $53603.7 billion in 2025.
  • Its last three reported values are $53603.7 billion in Q3 2025, $51637.8 billion for Q3 2024, and $33.5 million during Q1 2024.